# US 2023/0404973 A1 · New carbazole derivatives sensitizing cells to anti-cancer agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0404973 A1
- Document ID: US20230404973A1
- Status: Published application
- Kind: A1
- Application number: 17/767,744
- Filed: 2020-10-12
- Published: 2023-12-21
- Earliest claimed: 2019-10-11
- Assignees: Centre National De La Recherche Scientifique
- Applicants: Centre National De La Recherche Scientifique
- Inventors: Laurence LAFANECHÈRE; Renaud PRUDENT; Lauralie PERONNE; Marc BILLAUD; Audrey VERNET; Eric DENARIER; Patrick DALLEMAGNE; Sylvain RAULT; Peggy SUZANNE; Jean-charles LANCELOT; Serge PERATO; Aurélien LESNARD
- Web page: https://patentgrep.com/patent/US20230404973A1

## CPC

- A61K 31/403: condensed with carbocyclic rings, e.g. carbazole
- A61K 31/337: having four-membered rings, e.g. taxol
- A61P 35/00: Antineoplastic agents
- C07D 403/04: directly linked by a ring-member-to-ring-member bond
- A61L 2300/416: Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

The invention concerns a compound of formula (I), Formula (I), R, R1 and R2 are independently selected form the group consisting of: —a hydrogen atom, —a halogen atom, —an alkyl group, linear, cyclic or branched, saturated or unsaturated, possibly substituted, comprising from 1 to 10 carbon atoms, —an acyl group comprising from 1 to 10 carbon atoms, —a carboxyl group, —an amido group comprising from 1 to 10 carbon atoms, and —an imino group, possibly substituted by an alkyl group, linear, cyclic or branched, saturated or unsaturated, and wherein R3, R4, R5 and R6 are independently selected form the group consisting of: —a hydrogen atom, —a halogen atom, —a hydroxyl group, —an alkyl group, linear, cyclic or branched, saturated or unsaturated, possibly substituted, comprising from 1 to 10 carbon atoms, —an alkoxy group comprising from 1 to 10 carbon atoms, —an acyl group comprising from 1 to 10 carbon atoms, —a carbonate group from 1 to 10 carbon atoms, —a carboxyl group, and —a cyano group.

## Claims

### Claim 1

A compound of formula (I)
wherein R, R1 and R2 are independently selected form the group consisting of:
a hydrogen atom,
a halogen atom,
an optionally substituted linear, cyclic or branched, saturated or unsaturated, alkyl group comprising from 1 to carbon atoms,
an acyl group comprising from 1 to 10 carbon atoms,
a carboxyl group,
an amido group comprising from 1 to 10 carbon atoms, and
an imino group, optionally substituted by a linear, cyclic or branched, saturated or unsaturated alkyl group, and
wherein R3, R4, R5 and R6 are independently selected form the group consisting of:
a hydrogen atom,
a halogen atom,
a hydroxyl group,
an optionally substituted linear, cyclic or branched, saturated or unsaturated alkyl group comprising from 1 to carbon atoms,
an alkoxy group comprising from 1 to 10 carbon atoms,
an acyl group comprising from 1 to 10 carbon atoms,
a carbonate group from 1 to 10 carbon atoms,
a carboxyl group, and
a cyano group.

### Claim 2 (depends on 1)

The compound according to claim 1,
wherein R, R1 and R2 are independently selected from the group consisting of:
a hydrogen atom,
a halogen atom,
an alkyl group of formula —CnH2n+1−xXx, wherein X being is selected from the group consisting of a hydrogen atom, a halogen atom, a hydroxyl group, n is an integer between 1 and 10 and x is the number of X present in the alkyl group,
an acyl group of formula —C(O)ORa, wherein Ra is a linear and saturated alkyl group comprising from 1 to 9 carbon atoms,
an acyl group of formula —C(O)H,
a carboxyl group (—COOH),
an amido group of formula —C(O)NRb, wherein Rb is a linear and saturated alkyl group comprising from 1 to 9 carbon atoms, and
an imino group of formula —C═N—Rc, wherein Rc is selected from the group consisting of a hydrogen atom or a linear, saturated alkyl group comprising from 1 to 10 carbon atoms, and a phenyl group, and
wherein R3, R4, R5 and R6 are independently selected from the group consisting of:
a hydrogen atom,
a halogen atom,
a hydroxyl group,
a linear, saturated alkyl group of formula —CnH2n+1, wherein n is an integer between 1 and 10,
an alkoxy group of formula —ORd, wherein Rd is a linear and saturated alkyl group comprising from 1 to 9 carbon atoms,
an acyl group of formula —C(O)ORa, wherein Ra is a linear and saturated alkyl group comprising from 1 to 9 carbon atoms,
an acyl group of formula —C(O)Re, wherein Re is a hydrogen atom or a linear, cyclic or branched, saturated or unsaturated, optionally substituted alkyl group comprising from 1 to 10 carbon atoms,
a carbonate group comprising from 1 to 10 carbon atoms,
a carboxyl group (—COOH), and
a cyano group (—CN).

### Claim 3 (depends on 1)

The compound according to claim 1,
wherein R and R1 are independently selected from the group consisting of:
a hydrogen atom,
a halogen atom,
a linear, saturated alkyl group comprising from 1 to 10 carbon atoms,
wherein R2 is selected from the group consisting of:
a hydrogen atom,
a halogen atom,
an alkyl group of formula —CnH2n+1−xXx, wherein X is selected from the group consisting of a hydrogen atom, a halogen atom, a hydroxyl group, n is an integer between 1 and 10 and x is the number of X present in the alkyl group,
an acyl group of formula —C(O)ORa, wherein Ra is a linear and saturated alkyl group comprising from 1 to 9 carbon atoms,
an acyl group of formula —C(O)H,
a carboxyl group (—COOH),
an amido group of formula —C(O)NRb, wherein Rb is a linear and saturated alkyl group comprising from 1 to 9 carbon atoms, and
an imino group of formula —C═N—Rc, wherein Rc is selected from the group consisting of a hydrogen atom or a linear, saturated alkyl group comprising from 1 to 10 carbon atoms, and a phenyl group, wherein R3, R5 and R6 are independently selected from the group consisting of:
a hydrogen atom,
a halogen atom,
a linear, saturated alkyl group of formula —CnH2n+1, wherein n is an integer between 1 and 10, and
wherein R4 is selected from the group consisting of:
a hydrogen atom,
a halogen atom,
a hydroxyl group,
a linear, saturated alkyl group of formula —CnH2n+1, wherein n is an integer between 1 and 10,
an alkoxy group of formula —ORd, wherein Rd is a linear and saturated alkyl group comprising from 1 to 9 carbon atoms,
an acyl group of formula —C(O)ORa, wherein Ra is a linear and saturated alkyl group comprising from 1 to 9 carbon atoms,
an acyl group of formula —C(O)Re, wherein Re is a hydrogen atom or a linear, cyclic or branched, saturated or unsaturated, optionally substituted i alkyl group comprising from 1 to 10 carbon atoms,
a carbonate group of formula —OC(O)ORf, wherein Rf is a linear and saturated alkyl group comprising from 1 to 9 carbon atoms,
a carboxyl group (—COOH), and
a cyano group (—CN).

### Claim 4 (depends on 1)

The compound according to claim 1,
wherein R and R1 are independently selected from the group consisting of a hydrogen atom, a chloride atom and a methyl group,
wherein R2 is selected from the group consisting of a hydrogen atom, a methyl group, a —COH group, an alkyl group of formula —CH2X, wherein X is selected from the group consisting of a chloride atom, a bromide atom, a iodine atom and a hydroxyl group, an acyl group of formula —C(O)ORa, wherein Ra being is a methyl group or an ethyl group, an acyl group of formula —C(O)H, a carboxyl group (—COOH), an amido group of formula —C(O)NRb, wherein Rb is a methyl group or an ethyl group, and an imino group of formula —C═N—Rc, wherein Rc is a phenyl group,
wherein R3, R5 and R6 are independently selected from the group consisting of a hydrogen atom, a chloride atom, a methyl group and an ethyl group, and wherein R4 is selected from the group consisting of a hydrogen atom, a methyl group, a hydroxyl group, a chloride atom, a bromide atom, a fluoride atom, a iodine atom, an alkoxy group of formula —ORd, wherein Rd is a methyl group or an ethyl group, an acyl group of formula —C(O)ORa, wherein Ra is a methyl group or an ethyl group, an acyl group of formula —C(O)Re, wherein Re is a methyl group, an ethyl group, a linear propyl group, a linear pentyl group, —CH2CH2-cyclopentyl group and a (para-methyl)phenyl group, a carbonate group of formula —OC(O)ORf, wherein Rf is a methyl group or an ethyl group, a carboxyl group (—COOH), and a cyano group (—CN).

### Claim 5 (depends on 1)

The compound according to claim 1,
wherein R and R1 are independently selected from the group consisting of a hydrogen atom and a methyl group,
wherein R2 is selected from the group consisting of a hydrogen atom, a —COH group and a —CH2OH group,
wherein R3, R5 and R6 are independently selected from the group consisting of a hydrogen atom, a chloride atom and an ethyl group, and
wherein R4 is selected from the group consisting of a hydrogen atom, a hydroxyl group, a chloride atom, a bromide atom, a fluoride atom, a carbonate group of formula —OC(O)ORf, wherein Rf is an ethyl group and an acyl group of formula —C(O)ORa, wherein Ra is a methyl group.

### Claim 6 (depends on 1)

The compound according to claim 1, characterized in that at least three of the substituents selected from the group consisting of R3, R4, R5 and R6 are a hydrogen atom.

### Claim 7 (depends on 1)

The compound according to claim 1, characterized in that said compound is selected from the group consisting of

### Claim 8 (depends on 1)

A method of preparation of a compound according to claim 1, comprising a step a) of contacting a compound of formula (II)
with a compound of formula (III)
or a compound of formula (IV)
in the presence of an acid,
wherein R, R1 and R2 are independently selected from the group consisting of:
a hydrogen atom,
a halogen atom,
a linear, cyclic or branched, saturated or unsaturated, optionally substituted alkyl group comprising from 1 to 10 carbon atoms,
an acyl group comprising from 1 to 10 carbon atoms,
a carboxyl group,
an amido group comprising from 1 to 10 carbon atoms, and
an imino group, optionally substituted by a linear, cyclic or branched, saturated or unsaturated alkyl group and
wherein R3, R4, R5 and R6 are independently selected from the group consisting of:
a hydrogen atom,
a halogen atom,
a hydroxyl group,
a linear, cyclic or branched, saturated or unsaturated, optionally substituted alkyl group comprising from 1 to 10 carbon atoms,
an alkoxy group comprising from 1 to 10 carbon atoms,
an acyl group comprising from 1 to 10 carbon atoms,
a carbonate group from 1 to 10 carbon atoms,
a carboxyl group, and
a cyano group.

### Claim 9 (depends on 1)

A pharmaceutical composition, comprising at least one compound according to claim 1 and at least one pharmaceutically-acceptable excipient.

### Claim 10 (depends on 1)

A method for treating a disease and/or a disorder selected from the group consisting of a cancer and a disorder involving a deregulation of microtubules comprising administering to a mammal in need thereof a therapeutically effective amount of compound according to claim 1.

### Claim 11 (depends on 1)

A method for treating a cancer selected from the group consisting of a cancer in need of stabilization of cell microtubules, and a cancer induced by LKB1-deficient cells comprising administering to a mammal in need thereof a therapeutically effective amount of a compound according to claim 1.

### Claim 12 (depends on 1)

A method for treating a disease comprising administering to a mammal in need thereof a therapeutically effective amount of compound according to claim 1 wherein said compound is co-administered with at least one compound that stabilizes cell microtubules.

### Claim 13 (depends on 12)

The method according to claim 12, wherein said at least one compound that stabilizes cell microtubules is selected from the group consisting of taxanes, epothilones, TPI-287, carbazitaxel, zampanolide, dactylolide, discodermolide, taccalonolide, davunetide, eleutherobin, dictyostatin and sarcodictyins A and B.

### Claim 14 (depends on 12)

The method according to claim 12, wherein said at least one compound that stabilizes cell microtubules is paclitaxel.

### Claim 15 (depends on 1)

A method of treating a human or animal patient having LKB1-deficient cells, comprising administering to the human or animal patient a therapeutically effective amount of a compound of claim 1.
